Correlation Between Century Therapeutics and Xilio Development
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Xilio Development, you can compare the effects of market volatilities on Century Therapeutics and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Xilio Development.
Diversification Opportunities for Century Therapeutics and Xilio Development
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Century and Xilio is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Xilio Development go up and down completely randomly.
Pair Corralation between Century Therapeutics and Xilio Development
Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the Xilio Development. But the stock apears to be less risky and, when comparing its historical volatility, Century Therapeutics is 1.35 times less risky than Xilio Development. The stock trades about -0.05 of its potential returns per unit of risk. The Xilio Development is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 223.00 in Xilio Development on August 28, 2024 and sell it today you would lose (135.00) from holding Xilio Development or give up 60.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Century Therapeutics vs. Xilio Development
Performance |
| Timeline |
| Century Therapeutics |
| Xilio Development |
Century Therapeutics and Xilio Development Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Century Therapeutics and Xilio Development
The main advantage of trading using opposite Century Therapeutics and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.| Century Therapeutics vs. Eliem Therapeutics | Century Therapeutics vs. HCW Biologics | Century Therapeutics vs. Scpharmaceuticals | Century Therapeutics vs. Milestone Pharmaceuticals |
| Xilio Development vs. Connect Biopharma Holdings | Xilio Development vs. Tyra Biosciences | Xilio Development vs. RAPT Therapeutics | Xilio Development vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |